A back pain checklist (Vfrac) for use in primary care to identify older women with back pain due to un-diagnosed broken bones in the back
- Conditions
- Osteoporotic vertebral fractureMusculoskeletal DiseasesOsteoporosis
- Registration Number
- ISRCTN16550671
- Lead Sponsor
- niversity of Bristol
- Brief Summary
2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/30684069/ protocol (added 25/03/2019) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35284926/ results (added 19/06/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 1635
1. Willing and able to give informed consent for participation in the study
2. Self-reported back pain in the previous 4 months
3. Aged over 65 years
Current exclusion criteria as of 23/01/2019:
1. Aged 65 years or under
2. No self-reported back pain reported in the previous 4 months
3. Has already had a full spinal x-ray in the previous 4 months that is not available to the research team
4. Considered unsuitable to take part by their GP (e.g. cognitive impairment or near end of life)
Previous exclusion criteria:
1. Aged 65 years or under
2. No self-reported back pain reported in the previous 4 months
3. Has already had a full spinal x-ray in the previous 4 months
4. Considered unsuitable to take part by their GP (e.g. cognitive impairment or near end of life)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure will be the accuracy of the Vfrac tool as estimated by the sensitivity and specificity. We are aiming for a sensitivity and specificity of greater than 80% to justify subsequent exploration in a definitive trial. The method of measurement will be self-reported questionnaire data at recruitment followed by data collection in research clinic plus spinal radiograph as soon as possible after recruitment.
- Secondary Outcome Measures
Name Time Method <br> 1. Cost effectiveness of Vfrac based upon follow-up of women from the primary outcome cohort to identify if a future definitive cluster randomised controlled trial is appropriate<br> 2. Sources of variance that can be tested in a pilot as part of a future bid<br> 3. Stopping rules for a future trial. The output of this will be a decision on whether a future definitive trial is warranted.<br>